Healthways, Inc. (NASDAQ: HWAY) today announced that it intends to include in its proxy statement for its 2013 annual meeting of stockholders (the “2013 Annual Meeting”) a proposal to eliminate the Company’s classified board structure and elect directors on an annual basis. The proposal, which was unanimously approved by the Board of Directors, must be approved by the stockholders of the Company at the 2013 Annual Meeting.
The Board of Directors is currently divided into three classes, and each class of directors is elected for a three-year term. If the proposal is approved by stockholders, declassification of the Board of Directors will be implemented on a phase-out basis such that each class of directors would be elected for a one-year term beginning with the class of directors whose term expires at the Company’s 2014 annual meeting of stockholders. The full text of the proposal will be included in the Company’s proxy statement to be filed with the Securities and Exchange Commission in April, 2013.
Healthways is the largest independent global provider of well-being improvement solutions. Dedicated to creating a healthier world one person at a time, the Company uses the science of behavior change to produce and measure positive change in well-being for our customers, which include employers, integrated health systems, hospitals, physicians, health plans, communities and government entities. We provide highly specific and personalized support for each individual and their team of experts to optimize each participant’s health and productivity and to reduce health-related costs. Results are achieved by addressing longitudinal health risks and care needs of everyone in a given population. The Company has scaled its proprietary technology infrastructure and delivery capabilities developed over 30 years and now serves approximately 40 million people on four continents. Learn more at www.healthways.com.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts